Efficacy and safety of topical WBI‐1001 in patients with mild to moderate psoriasis: results from a randomized double‐blind placebo‐controlled, phase II trial - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of topical WBI‐1001 in patients with mild to moderate psoriasis: results from a randomized double‐blind placebo‐controlled, phase II trial

71

Citations

2

References

2011

Year

Robert Bissonnette, Chantal Bolduc, Catherine Maari, Simon Nigen, J. Webster, Lisa Tang, M. Lyle

Journal of the European Academy of Dermatology and Venereology

Abstract

Topical WBI-1001 induces rapid and significant improvement in patients with plaque psoriasis.

References

	Year	Citations

Page 1